EAACI CHAMPIONS VISION ZERO TO REDUCE ALLERGY, ASTHMA BURDEN

KUALA LUMPUR, June 12 (Bernama) -- The European Academy of Allergy and Clinical Immunology (EAACI) is calling for a new global health ambition through Vision Zero, a future free from the burden of allergy and asthma.

As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, this vision will serve as the central theme of the four-day EAACI Annual Congress 2026 in Istanbul, Türkiye, beginning June 12.

The congress will bring together thousands of clinicians, researchers and healthcare professionals to discuss the latest scientific advances and the future of allergy and asthma care, according to EAACI in a statement.

“Vision Zero reflects our determination to move beyond disease management and towards disease prevention and burden reduction. Through collaboration across research, clinical practice and public health, we can work towards a future where allergy and asthma no longer limit the lives of millions,” said EAACI President, María Torres.

EAACI believes scientific innovation, prevention strategies and coordinated policy action can significantly reduce the impact of allergic and respiratory diseases on individuals, families and societies rather than accepting them as an inevitable and growing public health challenge.

The congress will showcase emerging research and clinical developments in immunotherapy, environmental and genetic factors, digital health technologies, precision medicine and preventive approaches. Discussions will also address health equity and the need to ensure that advances in allergy and asthma care are accessible to patients worldwide.

Allergic diseases are among the most common chronic conditions globally, and their burden extends beyond healthcare to affect education, productivity, quality of life and mental wellbeing.

Against this backdrop, EAACI's Vision Zero initiative seeks to encourage long-term thinking about what is possible when scientific discovery is matched by effective implementation and policy support. The congress is expected to bring together experts worldwide to accelerate progress towards substantially reducing the burden of allergy and asthma.

-- BERNAMA